Abstract
Barrett’s Esophagus (BE) is a precancerous esophageal condition often associated with chronic gastroesophageal reflux, while the role of Helicobacter pylori (H. pylori) infection in its progression remains controversial. Oxidative stress and chronic inflammation are key factors in the advancement of esophageal metaplasia. In this context, hyperbaric ozone autohemotherapy (AHT-O₃) emerges as a promising adjuvant therapeutic option due to its antioxidant and immunomodulatory effects. This study included 60 patients with BE and active H. pylori infection, randomized into two equal groups: one treated with standard therapy combined with AHT-O₃, and one receiving standard therapy alone. Over a 12-month period, clinical, endoscopic, histological, and paraclinical evaluations were performed, including markers of oxidative stress, immunophenotyping, H. pylori infection status, CRP levels, GIQLI scores, and the dynamics of esophageal lesions. Ozone therapy led to a significant reduction in the oxidative stress marker malondialdehyde (MDA) and a notable increase in antioxidant enzymes (SOD, GPx, GST), indicating a restoration of redox balance. Concurrently, a significant increase in T-helper cells and a decrease in inflammatory T cells were observed, reflecting a favorable immune response. Parameters specific to H. pylori infection (IgA, IgG, fecal antigen) showed a more pronounced reduction in the ozone treatment group, indicating superior eradication efficiency. CRP levels decreased significantly, and GIQLI scores revealed a marked improvement in the quality of life. Endoscopic and histological assessments demonstrated a significantly higher rate of complete or partial regression of Barrett’s lesions in the ozone-treated group. Hyperbaric ozone autohemotherapy, when integrated into the standard therapeutic regimen, proved effective in counteracting oxidative stress, modulating immune responses, and significantly improving the clinical and histological status of patients with BE and H. pylori infection. These results support the use of this method as a complementary therapeutic strategy with added value in gastroenterology.

This publication has 34 references indexed in Scilit: